100 related articles for article (PubMed ID: 22134517)
21. [Treatment options in early-stage testicular seminoma. Review of the literature with initial results of a prospective multicenter study on radiotherapy of clinical-stage I, IIA and IIB seminomas].
Schmidberger H; Bamberg M
Strahlenther Onkol; 1995 Mar; 171(3):125-39. PubMed ID: 7709330
[TBL] [Abstract][Full Text] [Related]
22. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
25. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
[TBL] [Abstract][Full Text] [Related]
26. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
27. Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s).
Kusters JM; Louwe RJ; van Kollenburg PG; Kunze-Busch MC; Gidding CE; van Lindert EJ; Kaanders JH; Janssens GO
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1405-14. PubMed ID: 21300472
[TBL] [Abstract][Full Text] [Related]
28. [Long-term tumor control and fertility after para-aortic limited radiotherapy of stage I seminoma].
Sedlmayer F; Joos H; Deutschmann H; Rahim H; Merz F; Kogelnik HD
Strahlenther Onkol; 1999 Jul; 175(7):320-4. PubMed ID: 10432993
[TBL] [Abstract][Full Text] [Related]
29. Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal therapy (3DCRT) in breast cancer.
Selvaraj RN; Beriwal S; Pourarian RJ; Lalonde RJ; Chen A; Mehta K; Brunner G; Wagner KA; Yue NJ; Huq SM; Heron DE
Med Dosim; 2007; 32(4):299-304. PubMed ID: 17980832
[TBL] [Abstract][Full Text] [Related]
30. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
[TBL] [Abstract][Full Text] [Related]
31. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
[TBL] [Abstract][Full Text] [Related]
32. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
[TBL] [Abstract][Full Text] [Related]
33. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
[TBL] [Abstract][Full Text] [Related]
34. An imrt technique to increase therapeutic ratio of breast irradiation in patients with early-stage left breast cancer: limiting second malignancies.
Ahmed RS; De Los Santos JF; Fiveash JB; Keene KS; Popple RA
Med Dosim; 2008; 33(1):71-7. PubMed ID: 18262126
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients.
Andolino DL; Hoene T; Xiao L; Buchsbaum J; Chang AL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e667-71. PubMed ID: 21459527
[TBL] [Abstract][Full Text] [Related]
36. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
37. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
38. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
[TBL] [Abstract][Full Text] [Related]
39. [Does radiotherapy still have a place in the treatment of stage I seminoma?].
Paule B
Prog Urol; 2004 Jun; 14(3):281-6; discussion 285-6. PubMed ID: 15373167
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
